Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1956 Oct 31;104(5):675–686. doi: 10.1084/jem.104.5.675

STUDIES ON THE NATURE AND THE PURIFICATION OF THE COAGULASE-REACTING FACTOR AND ITS RELATION TO PROTHROMBIN

Morris Tager 1
PMCID: PMC2136617  PMID: 13367337

Abstract

The coagulase-reacting factor (CRF) of human plasma has been purified, concentrated, and largely freed of prothrombin activity by Seitz filtration, absorbtion on hyflo-amphogel columns, controlled phosphate buffer elution, and fractional ammonium sulfate precipitation. The purified CRF preparations localized between the beta and the gamma globulin position on paper electrophoresis, and the principal of two components observed on analytical ultracentrifugation gave sedimentation rates between 2.75 and 3.07. Highly purified prothrombin preparations of Seegers effectively react with staphylocoagulase to lead to the coagulation of plasma. The electrophoretic and ultracentrifugal properties of the human prothrombin preparations examined differ significantly from those of the purified CRF. Derivatives of prothrombin, involving a loss of prothrombin activity, such as thrombin and "autoprothrombin," do not correspondingly lose in CRF function. The hypothesis is proposed that CRF activity is resident in some component or components of the prothrombin molecule not involved in prothrombin function per se, and that therefore prothrombin and CRF activity may either parallel each other when the molecule is intact or diverge when the smaller units only are involved.

Full Text

The Full Text of this article is available as a PDF (654.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DUTHIE E. S., LORENZ L. L. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol. 1952 Feb;6(1-2):95–107. doi: 10.1099/00221287-6-1-2-95. [DOI] [PubMed] [Google Scholar]
  2. DUTHIE E. S., LORENZ L. Staphylococcal coagulase; the nature of plasma activator in the clotting process. Nature. 1950 May 6;165(4201):729–729. doi: 10.1038/165729b0. [DOI] [PubMed] [Google Scholar]
  3. LAMY F., WAUGH D. F. Certain physical properties of bovine prothrombin. J Biol Chem. 1953 Jul;203(1):489–499. [PubMed] [Google Scholar]
  4. MIALE J. B. Relationship of coagulase-globulin to prothrombin. Proc Soc Exp Biol Med. 1950 Nov;75(2):432–434. doi: 10.3181/00379727-75-18221. [DOI] [PubMed] [Google Scholar]
  5. SEEGERS W. H., ALKJAERSIG N. Comparative properties of purified human and bovine prothrombin. Am J Physiol. 1953 Mar;172(3):731–736. doi: 10.1152/ajplegacy.1953.172.3.731. [DOI] [PubMed] [Google Scholar]
  6. WARE A. G., STRAGNELL R. An improved one-stage prothrombin method. Am J Clin Pathol. 1952 Aug;22(8):791–797. doi: 10.1093/ajcp/22.8_ts.791. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES